BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4460243)

  • 1. [Indications of surheme in vascular disorders in otorhinolaryngology].
    Guerrier Y
    Sem Hop Ther; 1974 Nov; 50(9):585-8. PubMed ID: 4460243
    [No Abstract]   [Full Text] [Related]  

  • 2. [Surhème and lower limb arteriopathies].
    Journ Annu Diabetol Hotel Dieu; 1971 May; 12(0):273-6. PubMed ID: 5164780
    [No Abstract]   [Full Text] [Related]  

  • 3. [Indications of Surheme in otorhinolaryngology. Clinical, audiometric and electronystagmographic study].
    Bertoni R
    Therapeutique; 1971 Nov; 47(9):789-96. PubMed ID: 5147558
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and thermometric study of Surheme in 30 cases of cerebrovascular disorders].
    Balmes A; Piglowski J
    Therapeutique; 1973; 49(5):361-7. PubMed ID: 4781830
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of surheme in cochleo-vestibular disorders].
    Pech A; Gitenet P
    Sem Hop Ther; 1974 Apr; 50(4):281-6. PubMed ID: 4614447
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of surheme on improved blood flow in limbs].
    Wesolowski J; Hubl S; Godziemba-Maliszewska E
    Wiad Lek; 1972 Jul; 25(14):1297-300. PubMed ID: 5054661
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trial of butalamine].
    Traissac L
    Rev Laryngol Otol Rhinol (Bord); 1973; 94(9):465-72. PubMed ID: 4603409
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of arteriopathy of lower limbs by LA 1221].
    Ambrosi C; Jouve A
    Mars Med; 1970; 107(2):197-8. PubMed ID: 5424428
    [No Abstract]   [Full Text] [Related]  

  • 9. [Symptomatic treatment of allergies and seasonal infections of the field of otorhinolaryngology].
    Bourguet J; Du Plessis De Grenedan Y; Dumeyniou P
    Ann Otolaryngol Chir Cervicofac; 1974; 91(10-11):633-8. PubMed ID: 4469758
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis and treatment of cochleo-vestibular disorders (clinical study of Surheme)].
    el Seifi A
    Rev Laryngol Otol Rhinol (Bord); 1976; 97(3-4):181-8. PubMed ID: 827003
    [No Abstract]   [Full Text] [Related]  

  • 11. [Surheme in the treatment of cochleo-vestibular syndromes of vascular origin].
    Meunier JL; Forestier R
    Ann Otolaryngol Chir Cervicofac; 1973 Jun; 90(6):397-407. PubMed ID: 4541765
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of irrigor as a drug improving the coronary blood flow].
    Bolińska H; Kaluzna J
    Wiad Lek; 1970 Sep; 23(17):1491-3. PubMed ID: 5472083
    [No Abstract]   [Full Text] [Related]  

  • 13. [Surheme in rheumatology].
    Chabot J
    Therapeutique; 1971; 47(6):615-8. PubMed ID: 5571180
    [No Abstract]   [Full Text] [Related]  

  • 14. [Surheme in chronic obliterative arteriopathies of the lower limbs].
    Desruelles J; Waucampt JJ
    Lille Med; 1971 Jan; 16():Suppl 1:224-9. PubMed ID: 5162043
    [No Abstract]   [Full Text] [Related]  

  • 15. [Symptomatic treatment of ORL diseases in children with an antihistaminic-decongestant-analgesic combination].
    Bebear JP
    Rev Laryngol Otol Rhinol (Bord); 1975; 96(1-2):90-2. PubMed ID: 49912
    [No Abstract]   [Full Text] [Related]  

  • 16. An evaluation of vasodilator drugs in occlusive vascular disease by measurement.
    Gillespie JA
    Angiology; 1966 May; 17(5):280-8. PubMed ID: 5936944
    [No Abstract]   [Full Text] [Related]  

  • 17. [Correlations between reactive hyperemia and response to vasodilator agents in patients with obliterating arteriopathies of the lower limbs].
    Dabizzi RP; Fantini F; Cappelli G; Grandonico F
    Minerva Cardioangiol; 1970 May; 18(5):287-90. PubMed ID: 5515012
    [No Abstract]   [Full Text] [Related]  

  • 18. Vasodilator drugs in peripheral vascular disease.
    Coffman JD
    J Maine Med Assoc; 1975 Oct; 66(10):262-9. PubMed ID: 1104731
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison between xenon 133 and thermography in experimental study of a vasodilator agent].
    Beurey J; Weber M; Saussure M; Bertrand A; Robert J
    Bull Soc Fr Dermatol Syphiligr; 1972; 79(1):68-70. PubMed ID: 4565812
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of 1-(4-oxyphenyl)-1-oxy-2-n-butylaminoethane sulfate on peripheral vascular diseases].
    Giulini SM; Agus GB; De Cristoforo A
    Minerva Cardioangiol; 1973 Jun; 21(6):434-8. PubMed ID: 4146376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.